XW13325 Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5
Billable / valid for submission ICD10PCS Release FY2026-APR
Short description: Transfuse Convalesc Plasma in Periph Vein, Perc, New Tech 5
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026 | 2025-10-01 | 2026-03-31 | Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5 | yes |
| FY2026-APR | 2026-04-01 | current | Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5 | yes |
Related codes in XW1
- XW1 New Technology, Anatomical Regions, Transfusion
- XW1337A Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10
- XW133B8 Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133C8 Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133D7 Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW133E7 Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW133F8 Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133G8 Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133H9 Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
- XW133J8 Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133SB Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11
- XW133YB Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11
- XW14325 Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5
- XW1437A Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10
- XW143B8 Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143C8 Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143D7 Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
- XW143E7 Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
- XW143F8 Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143G8 Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8